Survival data can contain an unknown fraction of subjects who are "cured" in the sense of not being at risk of failure. We describe such data with cure-mixture models, which separately model cure status and the hazard of failure among non-cured subjects. No diagnostic currently exists for evaluating the fit of such models; the popular Schoenfeld residual (Schoenfeld, 1982 . Partial residuals for the proportional hazards regression-model. Biometrika 69, 239-241) is not applicable to data with cures. In this article, we propose a pseudo-residual, modeled on Schoenfeld's, to assess the fit of the survival regression in the non-cured fraction. Unlike Schoenfeld's approach, which tests the validity of the proportional hazards (PH) assumption, our method uses the full hazard and is thus also applicable to non-PH models. We derive the asymptotic distribution of the residuals and evaluate their performance by simulation in a range of parametric models. We apply our approach to data from a smoking cessation drug trial.
INTRODUCTION
When a survival curve reaches toward a positive asymptote, we infer that the sample contains some subjects who are "cured" in the sense of not being at risk for the event of interest. One commonly sees such data in studies of cancers that are subject to cure, such as some leukemias in children (Sy and Taylor, 2000; Weston and others, 2004; Lambert and others, 2007) , and in behavioral medicine, where intervention may lead to long-term abstinence from an undesirable behavior (such as smoking) in a fraction of subjects (Wileyto and others, 2005; Li and others, 2010) .
We describe such data with cure-mixture models, which simultaneously model the probability of membership in the cured fraction and the duration of survival in the non-cured fraction (Farewell, 1982; Yamaguchi, 1992; Peng and others, 1998) . Subjects who experience events are revealed to be non-cured, whereas those who are censored may be in either class. It is common to use the logistic model to describe group membership, but the complementary log-log arises naturally in certain situations Li and others, 2010) . It is generally preferable to use parametric models for the non-cured event hazards, because semiparametric models such as the Cox model (Li and others, 2001) include survival curves that need not decline to zero, rendering the cure fraction non-identifiable.
With non-cure data, one can evaluate the adequacy of the proportional hazards (PH) assumption via Schoenfeld's residual (Schoenfeld, 1982; Grambsch and Therneau, 1994) . Applying this method to curemixture data will not diagnose departures from proportionality in the non-cured hazards, because even if non-cured survival is of PH type, the marginal hazards are non-proportional and will likely be detected as such. There is currently no analogous method for examining the fit of the non-cured hazard in cure-mixture data. In this article, we adapt Schoenfeld's approach for use with parametric cure models. We establish our method's asymptotic properties, and verify its effectiveness by simulation. We apply it to time-to-quit data from a smoking cessation trial. Figure 1 (a) is a Kaplan-Meier plot of days to first cigarette in the placebo and active arms of a randomized trial (n = 357) of bupropion for smoking cessation. Both curves appear to reach toward positive asymptotes, the placebo curve perhaps more distinctly. An analysis with treatment as the sole predictor in a PH model estimates the hazard ratio (HR) for the active drug effect to be 0.69. The mean of the scaled Schoenfeld residuals (Figure 1(b) ) departs from a horizontal line at 0 with a significant trend, suggesting inadequacy of the PH assumption.
MOTIVATING EXAMPLE
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Residual plots of cure-mixture data can have this appearance even if the non-cured hazard follows a PH model exactly. Figure 1 (c) shows simulated data (n = 2000) from a logistic-Weibull cure model with odds ratio OR = 0.5 for the drug effect on non-cure, and HR=0.6 for the drug effect on survival among the noncured. A Cox regression yields HR = 0.52 (95% CI 0.47-0.58). Scaled Schoenfeld residuals (Figure 1(d) ) show a significant trend similar to that of our trial data. Heuristically, the problem is that in the cure model the rate of decline of the survival function, which normally provides the information on the HR, is confounded with the curve's horizontal asymptote, which is the cure probability. To eliminate this confounding, our proposed residual uses both hazard and cure information.
CURE MODELS
The cure-mixture model (Farewell, 1982; Yamaguchi, 1992; Peng and others, 1998) assumes the marginal survival function
where P is the probability of membership in the non-cured fraction and G(t) is the survival function given membership in the non-cured fraction. Farewell modeled P using logistic regression and G using Weibull PH regression (Farewell, 1982) . This is a latent-class model because cure status is indeterminate for some subjects: Those who experience an event are known to be in the non-cured fraction, whereas those who are censored may belong to either fraction. The naïve application to cure-mixture data of ordinary survival models such as Cox regression confounds estimates of hazard and predictor effects with cure probability. Thus, the survival model may identify effects that are properly associated with class membership rather than time to event (Sy and Taylor, 2000; Price and Manatunga, 2001) . The bias can be revealed by examining how the marginal or unconditional hazard h u (t) relates to the hazard h c (t) conditional on membership in the non-cured class. The unconditional hazard for a subject drawn from the mixture is
By comparison, the hazard for a subject known to be in the non-cured fraction is h c (t) = G (t)/G(t). Thus, the relationship between the conditional and unconditional hazards is given by h
which, for proper G(t), equals 1 for all t only if P = 1. We interpret w(t) as the conditional probability that a subject belongs to the non-cured fraction given survival to time t. Assuming a randomized trial with active and control arms, we define the conditional hazard for the non-cured fraction as h c1 (t) on active and h c0 (t) on control. The conditional HR for treatment, assuming PH, is then
By comparison, the unconditional HR is
where w 1 (t) and w 0 (t) are the values of w(t) for treatment and control, respectively.
DEFINITION AND PROPERTIES
Let X j = (X j1 , . . . , X j p ) be the vector of predictors for individual j and X (i) be the predictor vector for the individual who experiences the ith ordered failure at time t i . The Schoenfeld residualr i for subject i is the difference between the observed predictor value and the expected predictor value (averaged across the risk set R(t i ) at t i ), given that exactly one subject fails at t i :
whereβ is the vector of estimated coefficients in a standard PH model. Now assume the cure model (3.1) where for subject j the probability of cure is P j = expit(X j φ), the survival function given not cured is G j (t), and the hazard given not cured is
where β and φ are vectors of coefficients. We assume that X j contains all predictors that affect either cure or survival.
Our residual adapts the Schoenfeld residual to the cure model by using the unconditional hazard h u as the weight in calculating the average predictor vector. Setting
, and D i j to be the indicator that subject j died at the ith ordered event time t i , we define
(4.2)
Replacing coefficients with their maximum likelihood estimates (MLEs) in (4.2), β byβ and φ byφ, and settingˆ
It is equivalent to Schoenfeld's when the cure probability is assumed to be 0 and the survival model is of PH form.
In Appendix, we demonstrate that if the model is correctly specified using m coefficient parameters, then as n → ∞ the residualsr i have the following properties:
(4.4)
where C i is an m × p matrix of constants (see Appendix for details), I the Fisher information for (β, φ), and U the score function. 
PH, proportional hazards; AFT, accelerated failure time.
SIMULATION
We used simulation to examine the small-sample properties of the residuals and to explore patterns arising in the residuals when the assumed model is incorrect. An exhaustive study of possible misspecifications was impracticable. Instead, we focused on examples where data were generated from one commonly used survival distribution but fitted by another, and on the one case of a time-varying treatment effect, implemented by allowing the shape of the survival curve to differ between drug and placebo groups (Carroll, 2003) . We conducted all simulations in Stata Version 11 (Stata Corporation; College Station, TX), using the maximum-likelihood utility to estimate cure models. All simulations incorporated non-zero treatment effects on both survival and cure. We assumed a logistic cure component, with a placebo non-cure fraction of 80% and an OR for the drug effect of 0.7. We simulated from four different models for survival given not cured: the Weibull, Gompertz, log-normal, and log-logistic (see Table 1 ). For each model, we chose parameters so that total censoring in the non-cured class was roughly 10% at day 220; parameter values appear in Figure 2 . To simulate the mean residual across time, we generated 2000 replicates of data sets of n = 400 subjects at risk at day 0. For each simulated data set, we fitted each of the four models and calculated standardized residuals. Roughly 1 3 of the events were censored, including both cured and non-cured classes. We then smoothed each replicate of the standardized residuals over event time using lowess with a bandwidth of 0.4. Figure 2 displays mean smoothed residual curves, averaged across replicates. Frames A and C represent data generated under the Gompertz and Weibull models, respectively, which incorporate predictor effects with a PH assumption. Frames B and D represent data generated under log-logistic and log-normal models, respectively, which incorporate predictor effects with an accelerated failure time (AFT) assumption. Frame E represents a model with a time-varying predictor effect, which agrees with none of the assumed models. When the generating and fitting models agree, residuals behave as the theory predicts, taking a mean near zero at all times. When the generating and fitting models disagree, the overall mean residual is zero but the mean by time deviates from zero in a curvilinear fashion.
Similar patterns can arise from misspecification of the cure class membership model. Example plots appear in supplemental materials at Biostatistics online. Figure 2 demonstrates that visual inspection of the residual plot readily reveals inadequacy of the survival model. One can also extract a formal test from the analysis of patterns like those in Figure 2 . An obvious candidate is a χ 2 test on the sum of squared standardized residuals; at least with discrete predictors, however, the χ 2 approximation is poor. As shown in Equations (4.4)-(4.6), although the residuals converge to zero, their asymptotic variance is complicated, making derivation of a χ 2 test impracticable. Grambsch and Therneau (1994) proposed testing for a time trend in the Schoenfeld residual. We suggest instead testing a polynomial fit, because the curved patterns of residuals we have observed may not be detectable with a linear trend test. Although one would expect to be able to make such a test using the χ 2 distribution of the likelihood ratio (LR) statistic, in fact the distribution of this statistic appears to be nonstandard. For this reason, we recommend that one refers the polynomial LR χ 2 to an empirical distribution generated from a parametric bootstrap. The test proceeds as follows: First, one estimates the parametric cure model and calculates the residuals. Next, one estimates a polynomial regression of the residuals against t, t 2 , and t 3 , calculating the LR test of this model against an intercept-only model. To calculate the null distribution for this statistic, one generates M replicates (we recommend M = 400) under the cure model assuming the estimated parameters from the original data, restricting the datasets to have the same number of events as the original data. One then calculates the residuals, the polynomial fit, and the LR fit statistic for each of the M simulated data sets. This parametric bootstrap distribution of the LR statistic serves as the null distribution for the LR statistic from the original data.
TESTING FOR LACK OF FIT
In a second set of simulations, we generated data using selected parametric cure models described in Table 1 . We then fitted all four parametric models to each data set, using sample sizes of n = 500, 750, and 1000, with 200 replicates of each. For each fitted model, we calculated the LR fit statistic and null distribution (with M = 400) as described above. The LR statistic was deemed significant at level α if it fell above the 100(1 − α) centile of the null distribution. Figure 3 shows the power of the test as a function of sample size for selected combinations of fitted and true models. For each model, the type I error rate was roughly 5% regardless of the sample size. Power for mismatched models varied widely. Figure 3 shows some of the combinations corresponding to larger deviations from zero in Figure 2 . Combinations leading to smaller deviations were less powerful.
APPLICATION TO SMOKING DATA
We applied the method to the data of Figure 1 , assuming a logistic model for cure and a range of parametric models for survival given not cured. Figure 4 shows the resulting residual plots. The best model was the Weibull, where the non-cure rate for placebo subjects was estimated to be 73% with a drug effect OR of 0.69 (95% CI 0.46-1.04). The estimated HR for drug was 0.56 (95% CI 0.41-0.78), compared with the HR = 0.69 obtained from the Cox model without cure.
Our test gave p = 0.49 for the Weibull model, p = 0.27 for the Gompertz, p = 0.18 for the log-logistic, and p = 0.25 for the log-normal. Thus, although Weibull is the best both on the basis of appearance and p value, none of the models fits significantly badly. Schoenfeld residuals revealed a time trend, indicating a violation of the PH assumption with the treatment effect HR changing over time. Our Weibull cure-mixture residuals suggest the PH assumption is reasonable within the context of a cure model.
DISCUSSION
We have developed a Schoenfeld-like pseudo-residual to assess the fit of a parametric cure-mixture model. The Schoenfeld residual compares the predictor of the subject who fails at the ith failure event to its expectation, conditional on the risk set and assuming PH. Our residual differs in using the full estimated Like the original Schoenfeld residual, the plot of the smoothed cure-mixture pseudo-residual vs. event time describes a horizontal line at 0 when the model fits well. When the fit is poor, the smoothed residuals display a possibly nonlinear trend across time. One can evaluate the fit numerically with a parametric bootstrap test of a polynomial model for the residual.
A limitation of the procedure is its lack of specificity. In some cases, several models may fit equally well; the log-normal and log-logistic, for example, commonly yield similar residual patterns. The analysis may be of most value when there is some discrepancy between the inferences or predictions obtained under several models; in such cases one can use the diagnostic to identify the best-fitting model.
The residual is sensitive to departures from either component of the cure model. Our sense is that both parts of the model should include as many predictors as are available. We expect that in most situations using all available predictors will give an acceptably good fit for the cure portion of the model, particularly so when the predictors are categorical. As our simulations show, including the correct predictors is not sufficient to create a good fit for the model of survival given not cured; the residual will readily detect misspecification of the hazard function.
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APPENDIX: ASYMPTOTIC PROPERTIES OF THE PSEUDO-RESIDUALS
We first simplify the notation, defining θ = (β, φ),
If the model is correctly specified, then the hazard at time t i for a subject with predictor X j is h i j (θ ), and
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and
Moreover consider two time points t i and t l (i < l), and note that r i is defined conditionally on R(t i ) and r l conditionally on R(t l ). Let D i denote the vector of D i j . Then
This is because given the event that occurred at time t i , r i is a constant vector c p×1 , and because the identity of the subject who experienced an event at t l is unrelated to the identity of the subject who experienced an event at t i . We now expand r i in θ about the MLEθ :
That is,r
Note that at any given time u = t i
As noted in Oakes (1977) where I is the Fisher information and U is the score function. This completes the proof.
